PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.\', \'Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.\', \'Vir Biotechnology, San Francisco, CA 94158, USA.\', \'Center for Emerging and Re-emerging Infectious Diseases, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.\', \'Independent physician, 6828 Balerna, Switzerland.\', \'Clinical Research Unit, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.\', \'Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, 6900 Lugano, Switzerland.\', \'Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland. lpiccoli@vir.bio dcorti@vir.bio dveesler@uw.edu.\', \'Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. lpiccoli@vir.bio dcorti@vir.bio dveesler@uw.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1126/science.abi7994
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 34210893
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all